AZD-8309
Modify Date: 2024-01-11 16:58:11
AZD-8309 structure
|
Common Name | AZD-8309 | ||
|---|---|---|---|---|
| CAS Number | 333742-48-6 | Molecular Weight | 384.42 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C15H14F2N4O2S2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of AZD-8309AZD-8309 (AZD8309) is a potent and orally bioavailable CXCR2 antagonist that has been proposed to regulate the transmigration of neutrophils; significantly reduces MPO in the pancreas and lungs, and reduces intrapancreatic trypsin and elastase activity in caerulein-pancreatitis; also reduces cathepsin B activity and MPO in taurocholate-pancreatitis; also antagonises the CCR2b receptor but it is 10-fold less potent than at CXCR2. COPD Phase 1 Clinical |
| Name | AZD-8309 |
|---|
| Description | AZD-8309 (AZD8309) is a potent and orally bioavailable CXCR2 antagonist that has been proposed to regulate the transmigration of neutrophils; significantly reduces MPO in the pancreas and lungs, and reduces intrapancreatic trypsin and elastase activity in caerulein-pancreatitis; also reduces cathepsin B activity and MPO in taurocholate-pancreatitis; also antagonises the CCR2b receptor but it is 10-fold less potent than at CXCR2. COPD Phase 1 Clinical |
|---|---|
| References | References 1. Virtala R, et al. Clin Exp Allergy. 2012 Apr;42(4):590-6. 2. Leaker BR, et al. Respir Res. 2013 Dec 16;14:137. 3. Malla SR, et al. Pancreatology. 2016 Sep-Oct;16(5):761-9. View Related Products by Target Chemokine Receptor (CCR and CXCR) COPD |
| Molecular Formula | C15H14F2N4O2S2 |
|---|---|
| Molecular Weight | 384.42 |